Drug industry leaders size up Trump’s FDA commissioner nominee
Biopharmaceutical executives express cautious hope that President Trump's nominee Heidi Overton will bring stability to the FDA following his social media announcement praising her capabilities.
cen · 2026-08-19 00:00 UTC